Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ansstas

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cold Spring Harbor Molecular Case Studies|October 20, 2021
Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiencyKaram Khaddour, Michael Ansstas, George Ansstas
Gastrointestinal Endoscopy|December 22, 2019
Cherry pits causing colonic obstructionDaniel Lew, Michael Ansstas, Kenneth Park
Clinical Journal of Gastroenterology|February 25, 2021
Seronegative autoimmune enteropathy with duodenal sparing and colonic clues in an adult femaleAlbert Chong, Amir Kashani, Michael Ansstas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 30, 2023
BRAF/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case SeriesJacob Strelnikov, Alice Zhou, Omar Butt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency-Related Loss of HeterozygosityAlice Zhou, Omar Butt, Michael Ansstas, et al.
Hereditary Cancer in Clinical Practice|December 9, 2020
Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutationKaram Khaddour, Ryan C Fields, Michael Ansstas, et al.
Canadian Journal of Diabetes|December 16, 2014
Internal medicine resident training and provision of diabetes quality of care indicatorsBishnu P Devkota, Michael Ansstas, Jeffrey F Scherrer, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2021
Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanomaKaram Khaddour, Sangeeta Khanna, Michael Ansstas, et al.
Diagnostic and Therapeutic Endoscopy|September 10, 2010
Physician-controlled wire-guided cannulation of the minor papillaJohn T Maple, Lilah Mansour, Tarek Ammar, et al.
Gastrointestinal Endoscopy|July 16, 2010
Risk of post-ERCP pancreatitis with placement of self-expandable metallic stentsGregory A Coté, Nitin Kumar, Michael Ansstas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cold Spring Harbor Molecular Case Studies|October 20, 2021
Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiencyKaram Khaddour, Michael Ansstas, George Ansstas
Gastrointestinal Endoscopy|December 22, 2019
Cherry pits causing colonic obstructionDaniel Lew, Michael Ansstas, Kenneth Park
Clinical Journal of Gastroenterology|February 25, 2021
Seronegative autoimmune enteropathy with duodenal sparing and colonic clues in an adult femaleAlbert Chong, Amir Kashani, Michael Ansstas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 30, 2023
BRAF/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case SeriesJacob Strelnikov, Alice Zhou, Omar Butt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency-Related Loss of HeterozygosityAlice Zhou, Omar Butt, Michael Ansstas, et al.
Hereditary Cancer in Clinical Practice|December 9, 2020
Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutationKaram Khaddour, Ryan C Fields, Michael Ansstas, et al.
Canadian Journal of Diabetes|December 16, 2014
Internal medicine resident training and provision of diabetes quality of care indicatorsBishnu P Devkota, Michael Ansstas, Jeffrey F Scherrer, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2021
Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanomaKaram Khaddour, Sangeeta Khanna, Michael Ansstas, et al.
Diagnostic and Therapeutic Endoscopy|September 10, 2010
Physician-controlled wire-guided cannulation of the minor papillaJohn T Maple, Lilah Mansour, Tarek Ammar, et al.
Gastrointestinal Endoscopy|July 16, 2010
Risk of post-ERCP pancreatitis with placement of self-expandable metallic stentsGregory A Coté, Nitin Kumar, Michael Ansstas, et al.
Pageof 2